Q&A Part I with Dr. Wendy Tate, Author of Insights Accrual Prediction Algorithm
In every aspect of her research career, Dr. Wendy Tate, Director of Research Operations at Advarra, has been committed to
In every aspect of her research career, Dr. Wendy Tate, Director of Research Operations at Advarra, has been committed to
Centralizing subject binders and SOPs in an eRegulatory system streamlines remote monitoring, ensuring secure access, compliance, and future-ready workflows.
In clinical research, working with organizations that understand the ins and outs of the phase of your trial is key
In the race to address the COVID-19 pandemic, researchers have worked tirelessly the past year to produce a vaccine. Operation
A common trope in sci-fi movies involves concerns about potentially smashing into uncharted objects while traveling at warp speed or
It’s safe to say 2020 has been more unpredictable than anyone could imagine. Through these unprecedented times, we have worked to provide the
FDA has recently issued guidance relating to changes for Certificates of Confidentiality (CoCs) brought about by the 21st Century Cures
The data gathered in a clinical trial is often collected by many different people, including investigators and coordinators, and interpreted
The United States regulations governing research with humans pay special attention to two ethical concepts that may not be familiar
In our latest webinar, a panel of experts from research organizations, Community Health Centers (CHCs) and healthcare tech discussed racial
As part of FDA’s response to combat COVID-19, FDA convened its Vaccines and Related Biological Products Advisory Committee (VRBPAC). The
In a recent webinar, Advarra Executive Director of Biosafety Services Daniel Eisenman discussed the latest trends in genetically modified vaccine and immunotherapy studies. He also explored unique startup challenges for studies involving investigational products that contain engineered genetic materials. Due to time constraints he wasn’t able to answer all audience questions during the Q&A period, so he has answered some of the most popular questions in this blog.